A5022949802- Neonatal and fetal brain pathology
- Neonatal Respiratory Health Research
- Epilepsy research and treatment
- Infant Development and Preterm Care
- Blood Coagulation and Thrombosis Mechanisms
- Anesthesia and Neurotoxicity Research
- Metabolism and Genetic Disorders
- Cerebral Venous Sinus Thrombosis
- Neurology and Historical Studies
- Vascular Malformations Diagnosis and Treatment
- Genomics and Rare Diseases
- Congenital Heart Disease Studies
- Genetics and Neurodevelopmental Disorders
- Metabolism, Diabetes, and Cancer
- Neuroscience of respiration and sleep
- Diet and metabolism studies
- Neurological and metabolic disorders
- Cerebral Palsy and Movement Disorders
- EEG and Brain-Computer Interfaces
Eunice Kennedy Shriver National Institute of Child Health and Human Development
2025
Research Network (United States)
2025
Nationwide Children's Hospital
2012-2024
Karolinska Institutet
2024
Centre Hospitalier Universitaire Sainte-Justine
2024
Université de Montréal
2024
University of Florence
2024
Massachusetts General Hospital
2024
The Ohio State University
2012-2019
The Ohio State University Wexner Medical Center
2012-2017
<b><i>Background:</i></b> Extremely-low-birth-weight (ELBW; ≤1,000 g) infants are at high risk for neurodevelopmental impairments. Conventional brain MRI term-equivalent age is increasingly used prediction of outcomes. However, optimal models remain to be determined, especially cognitive <b><i>Objective:</i></b> The aim was evaluate the accuracy a data-driven scoring system predict <b><i>Methods:</i></b> 122 ELBW had...
•Lacosamide was given as second- or third-line therapy in 70% of the 47 neonates.•40% patients were prescribed lacosamide at discharge to home from hospital.•19% received through end 30-day follow-up period.•No new safety signal observed with use neonates.•Incidence rate cardiac arrest per 1000 patient-days 1.39 (95% CI 0.04-7.74). BackgroundThere is growing evidence supporting and effectiveness older children. However, minimal data are available for neonates. We aimed determine incidence...
This study aims to describe the frequency and characteristics of anticonvulsant medication treatments initiated in neonatal period.We analyzed a cohort neonates with seizure diagnosis who were discharged from institutions Pediatric Health Information System between 2007 2016. Adjusted risk ratios 95% confidence intervals for associated (≤ 28 days postnatal) initiation calculated via modified Poisson regression.A total 6,245 infants 47 included. There was decrease both phenobarbital within...
Consequences of neonatal cerebral venous infarct can be severe. However, we have identified a series neonates with unilateral temporal lobe infarcts, suspected to secondary superficial cortical thrombosis, who had relatively normal outcomes. Medical records were reviewed retrospectively. History, relevant studies, and outcomes for 7 patients are described. Most presented seizures. Neuroimaging showed hemorrhage surrounding ischemic change, which was initially attributed thrombosis the vein...